PSMAfore: A phase 3 study comparing 177Lu-PSMA-617 treatment with change in androgen receptor pathway inhibitor in taxane-naïve patients with mCRPC Meeting Abstract
| Authors: | Lorch, A.; Berthold, D.; Burger, I.; Morris, M.; Sartor, O.; Chi, K.; de Bono, J.; Shore, N.; Crosby, M.; Dalal, D.; Fizazi, K. |
| Abstract Title: | PSMAfore: A phase 3 study comparing 177Lu-PSMA-617 treatment with change in androgen receptor pathway inhibitor in taxane-naïve patients with mCRPC |
| Meeting Title: | 5th Swiss Oncology and Hematology Congress (SOHC) |
| Journal Title: | Swiss Medical Weekly |
| Volume: | 152 |
| Issue: | Suppl. 265 |
| Meeting Dates: | 2022 Nov 16-18 |
| Meeting Location: | Basel, Switzerland |
| ISSN: | 1424-7860 |
| Publisher: | E M H Swiss Medical Publishers Ltd |
| Date Published: | 2022-11-14 |
| Start Page: | 67S |
| Language: | English |
| ACCESSION: | WOS:000912385900114 |
| PROVIDER: | wos |
| DOI: | 10.57187/smw.2022.40034 |
| Notes: | Meeting Abstract: 89 -- Source: Wos |
